Benitec Biopharma, Inc.
2 clinical trials · Sponsor
◉ Watch Benitec Biopharma, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia (NCT06185673) | Benitec Biopharma, Inc. | 2023-11-28 |
| A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03433027) | Benitec Biopharma, Inc. | 2018-03-15 |
Track Benitec Biopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.